IPHA vs REGN: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Regeneron Pharmaceuticals Inc in 2026
IPHA
Innate Pharma Sa
$1.69
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | IPHA | REGN | Winner |
|---|---|---|---|
| Market Cap | $152.94M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.5% | 0.0% | REGN |
| Gross Margin | -384.4% | 44.6% | REGN |
Analyze IPHA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or REGN a better investment?
Comparing IPHA and REGN: Innate Pharma Sa has a market cap of $152.94M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and REGN?
IPHA (Innate Pharma Sa) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or REGN?
REGN has higher revenue growth at 0.0% vs -0.5% for IPHA.
Which company is more profitable: IPHA or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -384.4% for IPHA.
Which is the larger company: IPHA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $152.94M for IPHA.
Should I buy IPHA or REGN in 2026?
Both IPHA and REGN have investment merit. IPHA trades at $1.69 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and REGN stock?
Key differences: Market Cap ($152.94M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.5% vs 0.0%), Gross Margin (-384.4% vs 44.6%).